BTSG

BTSG

USD

BrightSpring Health Services Inc. Common Stock

$32.030-0.940 (-2.851%)

Reaalajas hind

Healthcare
Health Information Services
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$32.970

Kõrge

$33.825

Madal

$31.940

Maht

3.55M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

5.8B

Tööstusharu

Health Information Services

Riik

United States

Kauplemisstatistika

Keskmine maht

3.66M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $15.26Praegune $32.030Kõrge $35.01

Seotud uudised

Analyst Upgrades

BTIG Maintains Buy on BrightSpring Health, Raises Price Target to $41

BTIG analyst David Larsen maintains BrightSpring Health with a Buy and raises the price target from $30 to $41.

Vaata rohkem
BTIG Maintains Buy on BrightSpring Health, Raises Price Target to $41
Analyst Upgrades

UBS Maintains Buy on BrightSpring Health, Raises Price Target to $42

UBS analyst A.J. Rice maintains BrightSpring Health with a Buy and raises the price target from $35 to $42.

Vaata rohkem
UBS Maintains Buy on BrightSpring Health, Raises Price Target to $42
GlobeNewswire

BrightSpring Health Services, Inc. Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance

LOUISVILLE, Ky., Oct. 28, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex

Vaata rohkem
BrightSpring Health Services, Inc. Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
Analyst Upgrades

Morgan Stanley Maintains Overweight on BrightSpring Health, Raises Price Target to $32

Morgan Stanley analyst Erin Wright maintains BrightSpring Health with a Overweight and raises the price target from $25 to $32.

Vaata rohkem
Morgan Stanley Maintains Overweight on BrightSpring Health, Raises Price Target to $32
Analyst Upgrades

UBS Maintains Buy on BrightSpring Health, Raises Price Target to $35

UBS analyst A.J. Rice maintains BrightSpring Health with a Buy and raises the price target from $31 to $35.

Vaata rohkem
UBS Maintains Buy on BrightSpring Health, Raises Price Target to $35
GlobeNewswire

BrightSpring Health Services, Inc. to Announce Third Quarter 2025 Financial Results on October 31, 2025

LOUISVILLE, Ky., Oct. 08, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its third quarter 2025 financial results on